1 result(s) for
|PI Name||Protocol #||Title|
|Tom Beer||STUDY00020481||VAPORHCS/OHSU J: A randomized, open-label, multicenter, Phase 2b study to evaluate physical function, including balance and daily activity, in participants with castration-resistant prostate cancer treated with darolutamide or enzalutamide (Bayer 20609)|
You may also qualify for Phase 1 Program trials.
For more information: